WeLeader Biomedical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	127.82	174.97	94.69	100.73	111.52
Short-Term Investments	68.46	34.37	7.83	8.4	4.18
Trading Asset Securities	2.87	2.83	2.43	2.33	3.01
Cash & Short-Term Investments	199.15	212.17	104.95	111.45	118.71
Cash Growth	-	102.16%	-5.83%	-6.11%	-
Accounts Receivable	295.07	276.87	273.63	279.43	290.68
Other Receivables	0	0.02	0.05	0.1	1.03
Receivables	295.08	276.89	273.69	279.52	291.71
Inventory	125.37	99.06	69.67	62.73	55.89
Other Current Assets	3.9	3.2	2.11	1.02	2.11
Total Current Assets	623.49	591.32	450.42	454.73	468.42
Property, Plant & Equipment	1,435	1,341	1,194	1,086	351.66
Long-Term Investments	27.72	26.82	42.87	27.84	29.6
Other Intangible Assets	2.75	4.06	3.88	5.74	6.13
Long-Term Deferred Tax Assets	0.57	0.46	0.69	0.79	0.49
Other Long-Term Assets	34.07	34.63	36.02	25.24	26.8
Total Assets	2,124	1,998	1,728	1,600	883.09
Accounts Payable	217.59	183.54	143.19	155.28	160.65
Accrued Expenses	51.67	56.82	55.27	48.18	44.01
Short-Term Debt	2	80	57	121.03	53
Current Portion of Long-Term Debt	19.48	17.44	16.97	15.02	13.63
Current Portion of Leases	93.8	81.43	74.62	49.75	53.93
Current Income Taxes Payable	22.75	25.54	23.87	34.46	23.84
Current Unearned Revenue	5.12	1.52	0.34	0.7	1.95
Other Current Liabilities	13.33	22.71	30.43	14.13	12.81
Total Current Liabilities	425.74	469.01	401.69	438.54	363.81
Long-Term Debt	387.2	397.96	249.03	270.23	18.65
Long-Term Leases	224.67	219.94	228.38	245.22	142.99
Long-Term Deferred Tax Liabilities	-	-	-	-	0
Other Long-Term Liabilities	0.2	2.69	2.69	0.2	0.22
Total Liabilities	1,038	1,090	881.78	954.19	525.68
Common Stock	454.79	415.79	415.79	342.46	193.49
Additional Paid-In Capital	341.94	141.13	141.13	92.96	8.73
Retained Earnings	288.97	351.16	276.57	213.89	155.2
Comprehensive Income & Other	0.39	0.39	12.29	-3.01	-
Shareholders' Equity	1,086	908.47	845.78	646.3	357.41
Total Liabilities & Equity	2,124	1,998	1,728	1,600	883.09
Total Debt	727.15	796.77	626	701.25	282.19
Net Cash (Debt)	-528.01	-584.6	-521.05	-589.79	-163.49
Net Cash Per Share	-12.24	-14.01	-12.68	-19.38	-5.82
Filing Date Shares Outstanding	45.48	41.58	41.59	34.25	27.88
Total Common Shares Outstanding	45.48	41.58	41.59	34.25	27.88
Working Capital	197.75	122.31	48.73	16.19	104.61
Book Value Per Share	23.88	21.85	20.34	18.87	12.82
Tangible Book Value	1,083	904.41	841.9	640.56	351.28
Tangible Book Value Per Share	23.82	21.75	20.24	18.70	12.60
Land	652.61	652.61	652.61	657.23	4.62
Buildings	-	-	-	11.93	11.93
Machinery	19.56	19.46	28.53	25.97	24.65
Construction In Progress	407.08	318.14	144.95	7.43	0.38

Source: S&P Global Market Intelligence. Standard template. Financial Sources.